» Articles » PMID: 35669191

Association Between C-Reactive Protein and Risk of Amyotrophic Lateral Sclerosis: A Mendelian Randomization Study

Overview
Journal Front Genet
Date 2022 Jun 7
PMID 35669191
Authors
Affiliations
Soon will be listed here.
Abstract

Until now, the relationship between C-reactive protein (CRP) levels and amyotrophic lateral sclerosis (ALS) risk has not been fully established. It is necessary to assess whether there is a causal relationship between C-reactive protein levels and ALS risk. We aimed to determine whether CRP has causal effects on risk of ALS. In this present study, summary-level data for ALS (20,806 cases and 59,804 controls) was obtained from large analyses of genome-wide association studies. For instrumental variables, 37 single nucleotide polymorphisms that had been previously identified to be related to CRP levels were used, including 4 SNPs of conservative CRP genetic variants and 33 SNPs of liberal CRP genetic variants. MR estimates were calculated using the inverse-variance weighted method, supplemented by MR-Egger, weighted median, and MR-PRESSO methods. There was no significant causal relationship between genetically predicted CRP levels and ALS risk (OR = 1.123, 95% CI = 0.963-1.309, = 0.139) and results for the conservative CRP instruments were consistent (OR = 0.964, 95% CI = 0.830-1.119, = 0.628). Pleiotropic bias was not observed in this study. This study suggests that genetically predicted CRP levels may not be a causal risk factor for ALS.

Citing Articles

Rab Geranylgeranyltransferase Subunit Beta as a Potential Indicator to Assess the Progression of Amyotrophic Lateral Sclerosis.

Yang J, Xin C, Huo J, Li X, Dong H, Liu Q Brain Sci. 2023; 13(11).

PMID: 38002490 PMC: 10670085. DOI: 10.3390/brainsci13111531.


C-Reactive Protein: Pathophysiology, Diagnosis, False Test Results and a Novel Diagnostic Algorithm for Clinicians.

Mouliou D Diseases. 2023; 11(4).

PMID: 37873776 PMC: 10594506. DOI: 10.3390/diseases11040132.


Regulation of the Innate Immune System as a Therapeutic Approach to Supporting Respiratory Function in ALS.

McGrath M, Zhang R, Bracci P, Azhir A, Forrest B Cells. 2023; 12(7).

PMID: 37048104 PMC: 10093136. DOI: 10.3390/cells12071031.


Biomarkers and molecular mechanisms of Amyotrophic Lateral Sclerosis.

Chakraborty A, Diwan A AIMS Neurosci. 2023; 9(4):423-443.

PMID: 36660079 PMC: 9826749. DOI: 10.3934/Neuroscience.2022023.

References
1.
Xia K, Zhang L, Tang L, Huang T, Fan D . Assessing the role of blood pressure in amyotrophic lateral sclerosis: a Mendelian randomization study. Orphanet J Rare Dis. 2022; 17(1):56. PMC: 8848798. DOI: 10.1186/s13023-022-02212-0. View

2.
Cui C, Sun J, Pawitan Y, Piehl F, Chen H, Ingre C . Creatinine and C-reactive protein in amyotrophic lateral sclerosis, multiple sclerosis and Parkinson's disease. Brain Commun. 2021; 2(2):fcaa152. PMC: 7850290. DOI: 10.1093/braincomms/fcaa152. View

3.
Kamat M, Blackshaw J, Young R, Surendran P, Burgess S, Danesh J . PhenoScanner V2: an expanded tool for searching human genotype-phenotype associations. Bioinformatics. 2019; 35(22):4851-4853. PMC: 6853652. DOI: 10.1093/bioinformatics/btz469. View

4.
Li C, Yang W, Wei Q, Shang H . Causal Association of Leukocytes Count and Amyotrophic Lateral Sclerosis: a Mendelian Randomization Study. Mol Neurobiol. 2020; 57(11):4622-4627. DOI: 10.1007/s12035-020-02053-7. View

5.
Chen X, Yazdani S, Piehl F, Magnusson P, Fang F . Polygenic link between blood lipids and amyotrophic lateral sclerosis. Neurobiol Aging. 2018; 67:202.e1-202.e6. DOI: 10.1016/j.neurobiolaging.2018.03.022. View